Import Enfamil A.R. Infant Formula For Spit-Up Powder — Buy in Bulk from Supplier in Canada

Enfamil A.R. Infant Formula for Spit-Up Powder is a clinically formulated nutritional solution designed to reduce frequent spit-up in infants, aligning with guidelines from the American Academy of Pediatrics. The formula contains a thickened consistency due to the inclusion of rice starch as a primary thickening agent, which helps slow gastric emptying and minimizes regurgitation. It is supplied as a dry powder in sealed cans, with standard net weights of 12.5 oz and 21.1 oz per container, intended for preparation with water prior to feeding.

The product delivers essential nutrients including DHA and ARA, which are long-chain polyunsaturated fatty acids naturally present in breast milk and linked to neurodevelopmental outcomes. Proteins are partially hydrolyzed to enhance digestibility, reducing gastrointestinal discomfort. It contains no added sucrose or corn syrup solids, and the carbohydrate source is lactose, matching the composition of human milk. These features make it suitable for infants with mild to moderate reflux, though it is not intended for infants with cow’s milk protein allergy.

Buyers include importers supplying pediatric clinics, pharmacies, and retail chains in regions with high demand for specialized infant nutrition. The product is typically shipped in bulk cartons of 12 or 24 cans, with palletized loads available for containerized freight. Trade terms such as FOB and CIF are standard, and buyers should confirm the lot number and expiration date on each shipment. Packaging is designed for shelf stability and tamper resistance, with no refrigeration required prior to opening.

BMD Materials is an imported supplier of infant nutrition products based in Canada, operating as a distributor rather than a manufacturer. The listing indicates no direct production facility, and no details are provided regarding company size, years in operation, or client portfolio. The supplier’s trust tier is listed as 'harbor', suggesting basic verification through a logistics or import channel, but no third-party certifications or audit reports are referenced in the source data.

There is no evidence of clinical testing, private labeling, or exclusive distribution rights for Enfamil A.R. in this listing. The supplier does not claim ownership of the brand, nor does it provide contact information beyond the platform interface. Buyers should treat this as a sourcing intermediary and verify product authenticity, batch traceability, and import compliance directly with the supplier before placing orders.